TAVI: New trials and registries offer further welcome evidence – U.S. CoreValve, CHOICE, and GARY

The introduction of transcatheter aortic valve implantation (TAVI) has resulted in a paradigm shift in the treatment of patients with severe aortic stenosis. Data from the recent U.S CoreValve Trial suggest, for the first time, that TAVI is associated with a significantly higher rate of survival at...

Descripción completa

Detalles Bibliográficos
Autores principales: Pighi, Michele, Serdoz, Roberta, Kilic, Ismail Dogu, Sherif, Sara Abou, Lindsay, Alistair, Di Mario, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bloomsbury Qatar Foundation Journals 2014
Materias:
Lessons from the Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104381/
https://www.ncbi.nlm.nih.gov/pubmed/25054123
http://dx.doi.org/10.5339/gcsp.2014.12
_version_ 1782327251629506560
author Pighi, Michele
Serdoz, Roberta
Kilic, Ismail Dogu
Sherif, Sara Abou
Lindsay, Alistair
Di Mario, Carlo
author_facet Pighi, Michele
Serdoz, Roberta
Kilic, Ismail Dogu
Sherif, Sara Abou
Lindsay, Alistair
Di Mario, Carlo
author_sort Pighi, Michele
collection PubMed
description The introduction of transcatheter aortic valve implantation (TAVI) has resulted in a paradigm shift in the treatment of patients with severe aortic stenosis. Data from the recent U.S CoreValve Trial suggest, for the first time, that TAVI is associated with a significantly higher rate of survival at one year compared to surgical aortic valve replacement (SAVR) in the treatment of high-risk patients affected by severe aortic stenosis. The present review discusses this study and the current evidence about TAVI, for the treatment of severe aortic stenosis, from major trials and real world registries.
format Online
Article
Text
id pubmed-4104381
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Bloomsbury Qatar Foundation Journals
record_format MEDLINE/PubMed
spelling pubmed-41043812014-07-22 TAVI: New trials and registries offer further welcome evidence – U.S. CoreValve, CHOICE, and GARY Pighi, Michele Serdoz, Roberta Kilic, Ismail Dogu Sherif, Sara Abou Lindsay, Alistair Di Mario, Carlo Glob Cardiol Sci Pract Lessons from the Trials The introduction of transcatheter aortic valve implantation (TAVI) has resulted in a paradigm shift in the treatment of patients with severe aortic stenosis. Data from the recent U.S CoreValve Trial suggest, for the first time, that TAVI is associated with a significantly higher rate of survival at one year compared to surgical aortic valve replacement (SAVR) in the treatment of high-risk patients affected by severe aortic stenosis. The present review discusses this study and the current evidence about TAVI, for the treatment of severe aortic stenosis, from major trials and real world registries. Bloomsbury Qatar Foundation Journals 2014-01-29 /pmc/articles/PMC4104381/ /pubmed/25054123 http://dx.doi.org/10.5339/gcsp.2014.12 Text en © 2014 Pighi, Serdoz, Kilic, Sherif, Lindsay, Di Mario, licensee Bloomsbury Qatar Foundation Journals. This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Lessons from the Trials
Pighi, Michele
Serdoz, Roberta
Kilic, Ismail Dogu
Sherif, Sara Abou
Lindsay, Alistair
Di Mario, Carlo
TAVI: New trials and registries offer further welcome evidence – U.S. CoreValve, CHOICE, and GARY
title TAVI: New trials and registries offer further welcome evidence – U.S. CoreValve, CHOICE, and GARY
title_full TAVI: New trials and registries offer further welcome evidence – U.S. CoreValve, CHOICE, and GARY
title_fullStr TAVI: New trials and registries offer further welcome evidence – U.S. CoreValve, CHOICE, and GARY
title_full_unstemmed TAVI: New trials and registries offer further welcome evidence – U.S. CoreValve, CHOICE, and GARY
title_short TAVI: New trials and registries offer further welcome evidence – U.S. CoreValve, CHOICE, and GARY
title_sort tavi: new trials and registries offer further welcome evidence – u.s. corevalve, choice, and gary
topic Lessons from the Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104381/
https://www.ncbi.nlm.nih.gov/pubmed/25054123
http://dx.doi.org/10.5339/gcsp.2014.12
work_keys_str_mv AT pighimichele tavinewtrialsandregistriesofferfurtherwelcomeevidenceuscorevalvechoiceandgary
AT serdozroberta tavinewtrialsandregistriesofferfurtherwelcomeevidenceuscorevalvechoiceandgary
AT kilicismaildogu tavinewtrialsandregistriesofferfurtherwelcomeevidenceuscorevalvechoiceandgary
AT sherifsaraabou tavinewtrialsandregistriesofferfurtherwelcomeevidenceuscorevalvechoiceandgary
AT lindsayalistair tavinewtrialsandregistriesofferfurtherwelcomeevidenceuscorevalvechoiceandgary
AT dimariocarlo tavinewtrialsandregistriesofferfurtherwelcomeevidenceuscorevalvechoiceandgary

Ejemplares similares